From: Targeted mutation detection in breast cancer using MammaSeq™
ABL1 | CDK6 | FGFR3 | KDR | NOTCH1 |
AKT1 | CDKN1B | FGFR4 | KIT | NRAS |
AKT3 | CDKN2A | FOXA1 | KMT2C | PAK1 |
ALK | CDKN2B | GATA3 | KRAS* | PDGFRA |
AR | CTCF | GRB7 | MAP2K4 | PIK3CA |
ARID1A | CTNNB1 | HIST2H2BE* | MAP3K1 | PIK3R1 |
ATM | DNAH14 | HRAS* | MAP3K4 | PTCH1 |
AURKA | EGFR | IDH1* | MDM2 | PTEN |
AURKB | ERBB2 | IGF1R | MDM4 | RB1 |
BRAF | ERBB3 | IKBKB | MET | RET |
BRCA1 | ERBB4 | IKBKE | MTOR | RPTOR |
BRCA2 | ESR1 | INPP4B | MYC | RUNX1 |
CCND1 | EZH2* | INSR | NCOA3 | SMO |
CCNE1 | FGF19 | JAK2 | NCOR1 | STK11 |
CDH1 | FGFR1 | JAK3 | NCOR2 | TP53 |
CDK4 | FGFR2 | JUN* | NF1 |